China NMPA Product Recall - Manual wheelchair

The National Medical Products Administration (NMPA) published a recall notice on June 28, 2017, concerning manual wheelchairs manufactured by Anyang Zhongxin Medical Technology Co., Ltd. The company initiated a voluntary Level III recall for a specific batch of its manual wheelchairs, identified by batch number 20170107 and model SYIV-100-AH0. The primary issue prompting this recall was the non-compliance of the product's labeling with established standard requirements. This deviation from regulatory labeling standards necessitated the company's action. While specific inspection dates are not detailed in the provided document, the recall notification itself acts as a regulatory report. Under the oversight of the NMPA, Anyang Zhongxin Medical Technology Co., Ltd. is required to remove the affected products from the market. A Level III recall signifies that the product is unlikely to cause adverse health consequences, but the labeling non-compliance still warrants corrective action to ensure adherence to medical device regulations. The company proactively reported this issue through a 'Medical Device Recall Event Report Form,' demonstrating its commitment to addressing regulatory discrepancies. This incident underscores the importance of stringent adherence to labeling standards within the medical device industry, as mandated by regulatory bodies like the NMPA to safeguard public health and ensure product integrity.